— Know what they know.
Not Investment Advice

PULM NASDAQ

Pulmatrix, Inc.
1W: -2.5% 1M: +6.8% 3M: -9.2% YTD: -30.5% 1Y: -68.0% 3Y: -21.9% 5Y: -90.0%
$1.57
+0.03 (+1.95%)
 
Weekly Expected Move ±9.9%
$1 $1 $2 $2 $2
NASDAQ · Healthcare · Biotechnology · Tech Score Neutral · Power 47 · $5.7M mcap · 4M float · 1.23% daily turnover · Short 33% of daily vol

Supply Chain Overview

15 relationships
15
As Filer
counterparties named
0
As Counterparty
mentioned by others
4
Rel. Types
2021-11-09
Earliest Filing
2026-03-27
Latest Filing
partner: 7 acquirer: 5 target: 2 investor: 1

Counterparties (Filed by PULM)

15 relationships

Companies named in PULM's SEC 8-K filings as business counterparties.

Counterparty Ticker Relationship Summary Filing Date SEC
Pulmatrix, Inc. PULM acquirer Parent company acquiring Eos SENOLYTIX, Inc. in a merger transaction. 2026-03-27 View
Senotherapeutix, Inc. — investor Sole stockholder of Eos SENOLYTIX, Inc. entering a support agreement to facilitate the merger. 2026-03-27 View
PUOS Merger Sub, Inc. — acquirer Wholly owned subsidiary of Pulmatrix, Inc. merging with Eos SENOLYTIX, Inc. 2026-03-27 View
Cullgen Inc. — acquirer Target of proposed merger with Pulmatrix 2025-05-15 View
Cipla — partner Partner collaborating on clinical development of PUR1900 outside the United States 2025-05-15 View
Pulmatrix, Inc. PULM acquirer Parent company acquiring Cullgen Inc. in a merger transaction. 2025-04-10 View
Cullgen Inc. CULL target Target company being acquired by Pulmatrix, Inc. in a merger transaction. 2025-04-10 View
Cullgen Inc. — target Target company in the merger agreement. 2024-11-13 View
Pulmatrix, Inc. PULM acquirer Parent company acquiring Cullgen Inc. 2024-11-13 View
PCL Merger Sub, Inc. — partner Wholly owned subsidiary of Pulmatrix, Inc. involved in the merger. 2024-11-13 View
PCL Merger Sub II, LLC — partner Wholly owned subsidiary of Pulmatrix, Inc. involved in the merger. 2024-11-13 View
MannKind Corporation MNKD partner Cross license agreement and transfer of laboratory facility 2024-05-29 View
Pulmatrix, Inc. PULM partner Signatory to the Second Amendment to the Development and Commercialization Agreement 2021-11-09 View
Pulmatrix Operating Company, Inc. PULM partner Signatory to the Second Amendment to the Development and Commercialization Agreement 2021-11-09 View
Cipla Technologies, LLC — partner Signatory to the Second Amendment to the Development and Commercialization Agreement 2021-11-09 View
Recent 8-K Filings (20)
Filing Date Description Type SEC
2026-08-13 Earnings Release; Exhibits View
2026-05-15 Earnings Release; Exhibits View
2026-04-21 Regulation FD; Other Events; Exhibits View
2026-03-27 Material Agreement; Unregistered Equity Sales; Change in Control; Bylaws Amendment; Regulation FD; E Agreement View
2026-03-02 Termination of Material Definitive Agreement; Regulation FD Disclosure; Financial Statements and Exh View
2026-02-26 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-12-18 Regulation FD Disclosure; Other Events; Financial Statements and Exhibits View
2025-10-16 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-08-06 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-06-16 Submission of Matters to a Vote of Security Holders; Other Events View
2025-05-15 Completion of Acquisition or Disposition of Assets; Financial Statements and Exhibits Acquisition View
2025-04-10 Entry into Material Definitive Agreement; Changes in Control of Registrant; Financial Statements and Agreement View
2025-04-08 Submission of Matters to a Vote of Security Holders; Financial Statements and Exhibits View
2025-03-21 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-02-14 Amendments to Articles of Incorporation or Bylaws; Financial Statements and Exhibits View
2024-12-20 Submission of Matters to a Vote of Security Holders View
2024-11-13 Entry into Material Definitive Agreement; Changes in Control of Registrant; Departure/Election of Di Agreement View
2024-11-08 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2024-10-08 Shareholder Nominations View
2024-08-13 Results of Operations and Financial Condition; Financial Statements and Exhibits View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms